PTC
AVNS

Private Trust Company’s Avanos Medical AVNS Stock Holding History

Private Trust Company’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-684
Closed -$7.91K – 2551
2025
Q3 		$7.91K Buy
684
+346
+102% +$4.05K ﹤0.01% 1998
2025
Q2 		$4.14K Hold
338
– – ﹤0.01% 2121
2025
Q1 		$4.84K Hold
338
– – ﹤0.01% 2041
2024
Q4 		$5.38K Buy
338
+56
+20% +$1.11K ﹤0.01% 1953
2024
Q3 		$6.78K Buy
282
+15
+6% +$343 ﹤0.01% 1849
2024
Q2 		$5.32K Buy
267
+17
+7% +$331 ﹤0.01% 1903
2024
Q1 		$4.98K Sell
250
-8
-3% -$155 ﹤0.01% 1916
2023
Q4 		$5.79K Buy
258
+47
+22% +$970 ﹤0.01% 1866
2023
Q3 		$4.27K Hold
211
– – ﹤0.01% 1928
2023
Q2 		$5.39K Sell
211
-1
-0.5% -$26 ﹤0.01% 1862
2023
Q1 		$6.3K Buy
212
+8
+4% +$232 ﹤0.01% 1768
2022
Q4 		$6K Hold
204
– – ﹤0.01% 1717
2022
Q3 		$4K Sell
204
-7
-3% -$183 ﹤0.01% 1705
2022
Q2 		$6K Buy
+211
New +$6.06K ﹤0.01% 1664

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Private Trust Company's AVNS Position: Q4 2025 in Review

Private Trust Company sold out of Avanos Medical (AVNS) in Q4 2025, closing a stake of 684 shares — an estimated $7.91K sold.

Private Trust Company first reported a position in AVNS in Q2 2022 and held it in 14 quarters. The position peaked at $7.91K in Q3 2025. 274 funds tracked by Wall St. Rank hold AVNS as of Q4 2025.

  • Private Trust Company reported no remaining Avanos Medical position as of Q4 2025 after selling out during the quarter.
  • Private Trust Company sold 684 Avanos Medical shares in Q4 2025, an estimated $7.91K.
  • Private Trust Company first reported a position in Avanos Medical in Q2 2022 and held it in 14 quarters.
  • Private Trust Company's Avanos Medical position peaked at $7.91K in Q3 2025.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2025.

Based on Private Trust Company's 13F filing for Q4 2025, filed 26 Jan 2026.